Your shortcut for this week:
Read on for the foresight of the week and the full breakdown of what shaped healthcare AI 👇
Solutions and Launches
Conscientia Health (US): Launched a clinician-driven AI mental health platform for provider matching, clinical decision support, trigger identification and scheduling. The company says its model remains clinician-supervised and reports low hospitalization rates, though outcome claims should be treated as company-reported. [Link]
Enzo Health (US): Launched an AI-native, agentic EHR for home healthcare agencies. The system automates workflows from referral to billing, with Enzo reporting intake time reductions from 70 minutes to around 5 minutes and clinician charting time cuts of about 75%. [Link]
Tempus (US): Launched the next generation of Lens, its agentic AI platform for oncology drug development. The platform is used by 19 of the top 20 biopharma companies and can run analyses across more than 8.5 million de-identified patient records. [Link]
Weave (US): Launched an enterprise-grade Omnichannel AI Receptionist built with Google Cloud’s Gemini Enterprise Agent Platform. The system manages healthcare front-office conversations across voice and text, preserves context and escalates to staff when human support is needed. [Link]
NHS Shared Business Services & Salesforce (UK): Launched an AI-powered digital help centre for NHS finance and procurement support. Built on Salesforce’s Agentforce 360, it has reduced average handling times by 20%, with most cases now resolved within 24 hours. [Link]
Tata Elxsi (India) & OpenAna: Launched AnaTel™, an AI-native software development platform for healthcare and medtech, co-developed through Tata Elxsi’s STEP.UP program. The platform generates code, documentation, test cases and regulatory artifacts, with productivity improvements of up to 60%.[Link]
Governance, Policy, and Ethics
The Joint Commission (US): Launched a voluntary Responsible Use of AI in Healthcare certification for US healthcare organizations. The program assesses governance, safeguards, effective data management, risk reduction and monitoring, but does not certify individual AI products. [Link]
American Nurses Association (US): Released consensus findings from its AI in Nursing Practice Think Tank, calling for nurse-led guardrails, stronger AI literacy and clearer accountability around AI use in nursing. [Link]
Coalition for Health AI (US): Released governance playbooks covering eight domains for responsible AI adoption in healthcare. The guidance includes practical controls for areas such as risk assessment, data management and third-party vendor oversight. [Link]
Rotherham, Doncaster and South Humber NHS Foundation Trust (UK): Published an AI policy setting rules for acceptable use, governance and clinical responsibility. Public AI tools must not be used for clinical decisions or patient-identifiable data, and AI outputs require human review. [Link]
World Health Organization (Global): Unveiled a consultation draft on global long-term care standards as China scales AI-enabled long-term care systems. Experts highlighted the need for human oversight, privacy protection and rights-based governance as digital tools expand in care delivery. [Link]
Research and AI Advancements
AI Chatbot Use and Disclosure for Mental Health Among US Adolescents and Young Adults: Surveyed US youth and found that 19.2% had used AI chatbots for mental health advice. Among users, 63.3% had not disclosed this to anyone, while 91.7% rated the advice as somewhat or very helpful. [Link]
Mount Sinai (US): Created a Health & AI Policy Index mapping 240 healthcare AI policies published between 2016 and 2025. The study found that AI oversight is accelerating globally but remains fragmented, creating potential governance and compliance challenges for health systems. [Link]
AI for Predicting Exacerbations in KIDs with Asthma (AIRE-KIDS): Developed machine-learning models using electronic medical records to predict repeat asthma-related ED visits or hospital admissions in children within one year. [Link]
Calling Doctor GPT: Penn State researchers assessed large language models on everyday health questions, finding that responses were accurate 76.2% of the time. They also noted error rates above 20%, raising concerns about patient-facing medical advice. [Link]
AI in Lung Nodules on Chest CT: Evaluated an FDA-cleared AI lung nodule tool on 650 chest CTs, finding discordance with radiology reports in 84% of exams. [Link]
Partnerships & Adoption
Oura (Finland) & Counsel Health (US): Partnered to give Oura users direct access to physicians through the Oura app. The move reflects Oura’s shift from standalone wellness tracking toward more proactive healthcare support. [Link]
Advocate Health & Lind (US): Partnered to embed Lind’s AI trial-matching platform into the EHR for cancer clinical trial screening. [Link]
Medicalgorithmics (Poland) & Accyourate (Italy): Partnered to integrate Medicalgorithmics’ DRAI algorithms and DRP software with Accyourate’s wearable remote monitoring platform. [Link]
University of Oxford, Université Paris Cité & partners (UK/France): Launched a Health and AI alliance to connect cross-border research, infrastructure and data for major disease research, starting with women’s health, infectious diseases and pandemic preparedness. [Link]
IHH Healthcare (Global): Deployed AI-enabled tools including nurse rostering optimisation and revenue cycle automation across its 190-facility network. [Link]
Firstsource & AppliedAI (Global): Deployed a joint AI solution for healthcare provider data management, reducing processing time by up to 93%. [Link]
Bets on the Next Health System
Investments:
Garner Health (US): Index Ventures backed Garner Health, whose AI analyses billions of healthcare claims to help employers guide members toward doctors with better outcomes and lower total cost. [Link]
H1 (US): Received a $40 million investment led by CVS Health Ventures to expand its AI-powered doctor intelligence platform. [Link]
Triomics (US): Raised $22 million in Series B funding led by Battery Ventures to expand its oncology-specific AI platform. [Link]
Solstice (US): Raised $21 million in Series A funding led by Transformation Capital to expand its AI-native pharma marketing platform. [Link]
Signos (US): Raised $20 million from GV, Dexcom and Blue Cross Blue Shield of Alabama to scale its FDA-cleared CGM system for weight management. [Link]
Kubera Health (US): Raised $6.5 million in seed funding led by Upfront Ventures to build an AI-native contract-to-payment system for healthcare. [Link]
Lucis (France): Raised a $20 million Series A led by Singular to expand its AI-powered preventive health companion across Europe. The platform analyses 110+ blood biomarkers and provides physician-reviewed personalised health guidance. [Link]
Median Technologies (France): Launched a €40 million capital increase, with a potential upsize to €50 million, to support the US and European rollout of eyonis® LCS. [Link]
Oli (Australia): Raised $6.5 million to advance clinical trials, regulatory submissions and manufacturing for its wearable maternal-fetal monitoring device. [Link]
M&A:
Swoop (US): Acquired Nimble, adding prescription fulfilment and pharmacy connectivity to its healthcare engagement platform. Nimble supports 16 million patients across independent pharmacies in all 50 US states. [Link]
Jardine Matheson (Hong Kong): Agreed to acquire 100% of I-MED Radiology Network for A$3.4 billion, approximately US$2.4 billion. [Link]
That’s a wrap for Edition #33 of Health AI Foresight.
My goal with this newsletter is simple - to connect the present, the emerging, and the future of healthcare AI.
See you next week.
- Dr. Aboufandi
📩 Something stand out? Or have a suggestion? Hit reply - I read every message.